Predictors of long-term high on-treatment platelet reactivity in clopidogrel-treated patients undergoing coronary stenting for acute coronary syndrome

Int J Cardiol. 2013 Sep 30;168(2):1565-6. doi: 10.1016/j.ijcard.2012.12.062. Epub 2013 Jan 17.

Authors

Thomas Cuisset¹, Jacques Quilici, Pierre Emmanuel Morange, Jean-Louis Bonnet, Marie-Christine Alessi

Affiliation

¹ Département de Cardiologie, CHU Timone, Marseille, F-13385, France; INSERM, UMR1062, «Nutrition, Obesity and Risk of Thrombosis», F-13385, Marseille, France; Aix-Marseille Université, Faculté de Médecine, F-13385, Marseille, France. Electronic address: thomascuisset@voila.fr.

PMID: 23332898
DOI: 10.1016/j.ijcard.2012.12.062

No abstract available

Keywords: Acute coronary syndrome; Clopidogrel response; PRI VASP.

Publication types

Letter

MeSH terms

Acute Coronary Syndrome / blood
Acute Coronary Syndrome / drug therapy*
Acute Coronary Syndrome / surgery
Aged
Blood Platelets / drug effects*
Blood Platelets / physiology
Clopidogrel
Female
Humans
Male
Middle Aged
Percutaneous Coronary Intervention / trends*
Platelet Aggregation Inhibitors / pharmacology
Platelet Aggregation Inhibitors / therapeutic use*
Predictive Value of Tests
Prospective Studies
Ticlopidine / analogs & derivatives*
Ticlopidine / pharmacology
Ticlopidine / therapeutic use
Time Factors
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine